UroGen Pharma Ltd.
URGN | NASDAQ
$42.74
-$0.46 (-1.06%)
Sep 22, 2026, 12:23 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -37.93M | -23.57M | -26.36M | -33.35M | -49.94M | -43.84M | -37.51M | -23.67M | -33.4M | -32.29M | -26.02M | -21.88M | -24.14M | -30.21M | -28.25M | -25.83M | -26.69M | -28.39M | -28.45M | -30.21M | -26.22M | -25.94M |
Depreciation & Amortization | 1.32M | 652K | 679K | 639K | 596K | 497K | 306K | 266K | 263K | 351K | 424K | 415K | 431K | 435K | 450K | 435K | 476K | 456K | 451K | 452K | 442K | 428K |
Stock-Based Compensation | 9.96M | 4.63M | 3.13M | 3.03M | 2.73M | 3.07M | 3.3M | 3.49M | 3.56M | 2.76M | 2.61M | 2.22M | 2.22M | 2.29M | 2.37M | 2.44M | 2.82M | 2.95M | 5.36M | 5.52M | 6.05M | 6.2M |
Other Working Capital | -3.08M | -10.92M | 2.9M | -7.45M | 4.15M | -7.78M | 6.88M | 483.31K | 427K | -5.35M | 7.37M | -1.38M | 1.32M | -5.06M | 761.95K | -1.28M | -1.05M | -3.76M | 305K | -2.44M | 2.24M | -7.79M |
Other Non-Cash Items | 2.98M | 3.06M | 2.49M | 915K | 1.55M | 839K | 4.79M | 1.38M | 3.27M | 1.46M | 7.59M | 222K | 3.15M | 2.92M | 6.5M | 7.32M | 8.01M | 4.62M | 7.23M | 6.87M | 2.07M | -209K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.25M | 2.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -54.65M | -30.08M | -18.26M | -13.5M | 5.24M | -2.59M | 15.49M | -9.12M | 2.57M | -4.01M | 6.58M | -1.06M | -1.95M | -1.24M | 803.16K | 1.37M | -4.9M | -3.63M | -4.65M | -1.1M | -1.28M | -7.88M |
Operating Cash Flow | -78.32M | -45.32M | -38.33M | -42.27M | -39.83M | -42.02M | -13.62M | -27.66M | -23.75M | -31.74M | -13.06M | -17.3M | -20.27M | -25.81M | -20.49M | -16.7M | -23.11M | -24M | -20.07M | -18.48M | -18.95M | -27.4M |
Capital Expenditures | -114K | -54K | -17K | -87K | -141K | -44K | -115K | -96K | -84K | n/a | -53.54K | -100K | -15K | -23K | -10.87K | -147.66K | -61.02K | -25K | -202K | -194K | -69K | -287K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.29M | -501K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -24.78M | -24.78M | -11.05M | -8.72M | -1.79M | -66.35M | -9.23M | -118.79M | n/a | n/a | -14.18M | -10.83M | n/a | -24.18M | 429.45K | -61.09M | n/a | n/a | n/a | n/a | -41.66M | n/a |
Sales Maturities Of Investments | 5.88M | 4.15M | 98.82M | 40.21M | 30.34M | 40.43M | 69.97M | 12.14M | 12.08M | 13.52M | 3.25M | 11.33M | 3.74M | 30.47M | 21.98M | 26.72M | -393.26K | 13.62M | 9.63M | 20.79M | 10.98M | 15.31M |
Other Investing Acitivies | n/a | n/a | -60.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.65M | 501K | n/a | n/a | n/a | n/a | -1 | n/a | 9.33M | 10.85M | n/a | n/a |
Investing Cash Flow | -19.02M | -20.69M | 27.72M | 31.4M | 28.41M | -25.96M | 60.62M | -106.75M | 12M | 13.52M | -11.34M | 401K | 3.72M | 6.27M | 22.4M | -34.52M | -454.28K | 13.6M | 9.13M | 10.66M | -30.74M | 15.02M |
Debt Repayment | 64.64M | -321K | -1.97M | n/a | n/a | n/a | -24.39M | 24.39M | n/a | n/a | n/a | n/a | n/a | n/a | 23.58M | -553.69K | -1.63M | 70.83M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15K | -52K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 65.35M | 33.32M | n/a | n/a | n/a | 175.63M | 210.07K | 18.78M | 54.66M | 417.96K | 48.72M | 143K | 671K | 378K | 1.1M | -39K | -89K | -17K | -116K | 72.52M | 4K |
Financial Cash Flow | 65.7M | 65.2M | 31.32M | 8.27M | 296K | 34K | 71K | 39.61M | 100.29M | 54.66M | 40K | 116.08M | 143K | 671K | 23.94M | 514.87K | -1.67M | 70.74M | -32K | -168K | 72.52M | 4K |
Net Cash Flow | -31.63M | -800K | 20.71M | -2.6M | -11.12M | -67.95M | 47.07M | -94.81M | 88.54M | 36.44M | -24.3M | 99.18M | -16.41M | -18.87M | 26.72M | -52M | -24.43M | 60.34M | -10.98M | -7.98M | 22.83M | -12.37M |
Free Cash Flow | -78.44M | -45.37M | -38.34M | -42.36M | -39.97M | -42.07M | -13.73M | -27.76M | -23.83M | -31.74M | -13.11M | -17.4M | -20.29M | -25.83M | -20.51M | -16.85M | -23.17M | -24.02M | -20.27M | -18.67M | -19.01M | -27.69M |
Adj. Free Cash Flow | -88.39M | -50M | -41.47M | -45.38M | -42.7M | -45.14M | -17.04M | -31.25M | -27.39M | -34.49M | -15.72M | -19.62M | -22.51M | -28.12M | -22.87M | -19.29M | -26M | -26.97M | -25.63M | -24.19M | -25.06M | -33.88M |
Maintenance CapEx | -114K | -54K | n/a | n/a | n/a | n/a | -35.55K | n/a | -29.58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | -17K | -87K | -141K | -44K | -79.45K | -96K | -54.42K | n/a | -53.54K | -100K | -15K | -23K | -10.87K | -147.66K | -61.02K | -25K | -202K | -194K | -69K | -287K |
Owner Earnings | -78.44M | -45.37M | -38.33M | -42.27M | -39.83M | -42.02M | -13.65M | -27.66M | -23.78M | -31.74M | -13.06M | -17.3M | -20.27M | -25.81M | -20.49M | -16.7M | -23.11M | -24M | -20.07M | -18.48M | -18.95M | -27.4M |
Add to Watchlist
Select watchlists to add or remove URGN